| NEWRON PHARMACEUT. EO-,20 |
| Italien |
| Gesundheit |
| IT0004147952 / A0LF18 |
| NP5 (Frankfurt) |
| FRA:NP5, ETR:NP5, NP5:GR |
| - |
| https://www.newron.com/ |
|
Newron Pharmaceuticals SpA is a biopharmaceutical company headquartered in Bresso near Milan, Italy, specializing in the development of neuroscience-based treatments. Founded in 1999, the company focuses on advancing innovative therapies from discove..
>Volltext.. |
| 349.74 Mio. EUR |
| 359.01 Mio. EUR |
| 19.61 Mio. EUR |
| -4.6 Mio. EUR |
| -13.49 Mio. EUR |
| -0.68 EUR |
| 38.8 Mio. EUR |
| 12.39 Mio. EUR |
| 32.97 Mio. EUR |
| 0.58 |
| -62.69% |
| -184.35% |
| - |
| - |
| - |
| - |
| NEWRON |
| 05.04.26 |
|
||||
|
||||
|
||||
|